Feb 24, 2021 / 01:30PM GMT
Operator
Good day, and welcome to the bioMérieux yearly business review Conference Call. Today's conference is being recorded.
At this time, I would like to turn the conference over to Frank Admant. Please go ahead.
Franck Admant - bioMérieux S.A.-Director of IR
Thank you, Mary. Good day, everyone, and thank you for joining us to review bioMérieux performance for 2020 and our Objective for 2021.
Before leaving the floor to Alexandre Mérieux, Chairman and CEO; and Guillaume Bouhours, our CFO. I will just make a very short introduction to provide you a couple of information.
First of all, our press release will -- was released this morning at 7:00 a.m. this press release can be found on our -- the web -- on page of our website. In addition, please note that the slides of this meeting will be available on the room page of our website and can be downloaded directly from the webcast. Promptly after the call, the webcast and the call will be available in replay on our website.
Now going to the
Full Year 2020 Biomerieux SA Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot